Search results
FDA Approves Biosimilars for Macular Degeneration Treatment
Healthline via AOL· 2 days agoThe FDA approved two interchangeable biosimilars to treat macular degeneration. The biosimilars work...
FDA grants approval for two Eylea biosimilars for eye conditions
Pharmaceutical Technology via Yahoo Finance· 3 days agoYesafili is a trademark of Biosimilars Newco, a Biocon Biologics company. Opuviz is a trademark of...
Biocon Biologics Obtains U.S. FDA Approval for Biosimilar Aflibercept for Yesafili™. Enters U.S....
WTRF Wheeling· 3 days agoBiocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), today announced that the U.S. Food and Drug Administration ...
Kodiak Sciences Inc. (NASDAQ:KOD) Receives $5.50 Average Price Target from Analysts
ETF DAILY NEWS· 6 hours agoShares of Kodiak Sciences Inc. (NASDAQ:KOD – Get Free Report) have received an average recommendation of “Reduce” from the seven analysts that are currently covering the company, Marketbeat.com ...
Biocon Biologics gets US FDA nod for biosimilar version of eye treatment drug Eylea
Investing.com· 3 days agoBiocon Biologics gets US FDA nod for biosimilar version of eye treatment drug Eylea
Foundation Fighting Blindness to Host VISIONS 2024 Conference
WFRV 5 Green Bay· 7 days ago...PRNewswire/ -- The Foundation Fighting Blindness, the driving force in the global development of treatments and cures for blinding diseases, will host its VISIONS 2024 conference at the Chicago Marriott Downtown...diseases such as retinitis pigmentosa, Usher syndrome, Stargardt disease, Leber...
6 Everyday Habits That You Didn't Know Are Ruining Your Vision
CNET· 3 days agoIf you've never experienced any issues with your vision or your eye health for that matter, then you...
FDA approves 2 Eylea biosimilars
Becker’s Hospital Review· 4 days agoThe FDA granted approval to Biocon Biologics' drug Yesafili and Samsung Bioepis and Biogen's drug Opuviz, the agency announced May 20. The two drugs are biosimilars for Eylea, an injection made ...
Victoria Eye Center Notifies Over 80k of Recent Data Breach | JD Supra
JD Supra· 2 days agoOn May 13, 2024, Victoria Eye Center / Victoria Surgery Center / Victoria Vision Center (“VEC”) filed a notice of data breach with the Attorney General of Maine after discovering that files ...
Foundation Fighting Blindness Awards Inaugural Grants in PRPH2 and Associated Retinal Diseases...
WKRN Nashville· 2 days agoThe Foundation Fighting Blindness, the driving force in the global development of treatments and cures for blinding diseases, has announced the recipients of the first awards ...